MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER (NCT07458022) | Clinical Trial Compass
Active — Not RecruitingPhase 2
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
Pakistan50 participantsStarted 2025-12-01
Plain-language summary
Role of Magnesium in Depressive Disorder
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
All patients of above 18 years diagnosed with DSM who had MDD and receiving SSRI alone and SSRI plus magnesium.
Exclusion Criteria:
Individuals who recently underwent treatment with electroconvulsive therapy, have a history of epilepsy or other severe neurological problems, have experienced a head injury, are cognitively impaired, and have comorbid conditions such as liver, renal, cardiovascular, neurological, or endocrine, or respiratory problems, or are pregnant or nursing mothers
What they're measuring
1
Change in severity of depressive symptoms
Timeframe: Four Weeks
Trial details
NCT IDNCT07458022
SponsorUniversity of Child Health Sciences and Children's Hospital, Lahore